Residency Program Director
Claire Murphy, PharmD, BCPS, FCCM
- Lead Specialty Practice Pharmacist – Critical Care
- PGY2 Critical Care Residency Program Director, The Ohio State University Wexner Medical Center
- PharmD-St. Louis College of Pharmacy
- PGY1/PGY2 Pharmacotherapy Residency- Barnes-Jewish Hospital
Previous Year Residents
Megan Phelps, PharmDClinical Pharmacy Specialist, Trauma/SICU, UK Health Center
Megan Feeney, PharmDClinical Pharmacy Specialist, Medical/Cardiac ICU, Boston Medical Center
Jessica Biedny, PharmDNeurosurgical and Surgical Intensive Care Unit Pharmacy Specialist, Cleveland Clinic
Chris Miller, PharmDCritical Care/OR Clinical Pharmacist, University of Colorado Hospital
Justin Kaplan, PharmDSICU Clinical Pharmacist, Hackensack University Medical Center
Megan Jaynes, PharmD, BCCPNeurosciences Critical Care Clinical Pharmacist, Vanderbilt University Medical Center
About the PGY2 Critical Care Residency Program
PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in advanced or specialized practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge incorporating both into the provision of patient care that improves medication therapy. Residents who successfully complete an accredited PGY2 pharmacy residency should possess competencies that qualify them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification in that practice area (when board certification for the practice area exists).
Residents completing this residency program will have a well-rounded experience in caring for medical, surgical, neurosciences and cardiovascular critical care populations. The residency program is designed to develop independent critical care pharmacists specialized in providing direct and indirect patient care to critical care patients as a part of an interdisciplinary team. In addition, the resident will learn to independently perform research and process improvement projects, participate in medical emergencies and educate other pharmacists, healthcare professionals, and students.
As one of America’s top ranked academic medical centers, the mission of The Ohio State University Wexner Medical Center (OSUWMC) is to improve people’s lives through innovation in research, education and patient care. OSUWMC is a 1350 bed multi-hospital delivery system recognized in 2015 as one of “America’s Best Hospitals” for excellence in ten specialties by US News and World Report based on quality, outcomes, and reputation.Read about the sites
University Hospital (UH)
University Hospital (UH) is our flagship hospital with over 900 beds. UH is a major referral center for patients throughout Ohio and the Midwest, and is one of the busiest kidney and pancreas transplant centers in the world. UH is also an international center for neuromodulation research and neurological care. In addition, UH is a level 1 trauma center in addition to being the American Burn Associated verified adult burn center for the region.
The James Cancer Hospital and Solove Research Institute
The James Cancer Hospital and Solove Research Institute is one of the nation’s premier centers for the prevention, detection and treatment of cancer. OSUWMC features the world’s most advanced cancer and critical care hospital which opened in December of 2014.
With the opening of the new hospital, our institution boasts an Emergency Department (ED) with over 100 beds and an area dedicated specifically to the care of cancer patients within the ED. Medical Intensive Care, Surgical Intensive Care, Neuro Intensive Care, and Cancer specific ICU patient care areas also exist within the new critical care tower. Between UH and the new ICUs within the James Cancer Hospital, the Medical Center has 4 Medical ICU services, 3 Surgical ICU services, and 1 Neurocritical Care service totaling over 100 ICU beds.
The Ross Heart Hospital
The Ross Heart Hospital is a leader in cardiology and heart surgery and is the only nationally ranked heart hospital in the area. Each floor of the 172-bed hospital is dedicated to a specific service, which helps us provide specialized care for every patient. The Ross is one of the largest centers for the implantation of LVAD devices in the world in addition to providing heart and lung transplants.
University Hospitals East (UHE)
University Hospitals East (UHE) blends the friendly atmosphere of a community hospital with the advantages of being a part of a major academic medical center. Located on the eastern edge of downtown Columbus, University Hospital East offers renowned Ohio State services in orthopedic care, emergency services, cancer care, addiction services, ear, nose and throat care, heart care, radiology and imaging services, rehabilitation and wound healing. University Hospital East has a 19 bed mixed medical/surgical ICU.
The Brain and Spine Hospital
The Brain and Spine Hospital opened in the Fall of 2016 and is a state-of-the-art facility for the advanced management, care and healing of patients with neurological disorders.The hospital consists of 87 private beds and specialized units for stroke and neurovascular, neurotrauma, epilipsy, spine, chronic pain, neuromodulaton, multiple sclerosis, congnitive and movement disorders, as well as an innovative new model for acute spinal cord injuries.
The Department of Pharmacy
The Department of Pharmacy at The OSUWMC is one of the largest in the country. With over 400 employees, and a practice model that includes both clinical pharmacy generalists and clinical pharmacy specialists, our goal is the provision of outstanding, state of the art care. We advise our staff on the best use of medications, develop safeguards for our patients to prevent medication errors and develop transformative pharmacy practice in health-systems. We are guided in this mission by our strategic plan that focuses on five key priorities: optimizing our pharmacy information system, refining our practice model, enhancing our medication safety program, establishing the pharmacy as a workplace of choice in Central Ohio and refining our academic relationships and department scholarship.
Training future generations of pharmacists is a vital part of our mission. Our pharmacists serve as preceptors for our residency programs while providing experiential training for Doctor of Pharmacy (PharmD) students. Our residency program has a 55-year tradition of excellence with our graduates being well-prepared to work at a high-level in a wide-variety of institutional and ambulatory patient care facilities.
The Department of Pharmacy, in partnership with the Ohio State College of Pharmacy, strives to develop the skills of our residents and provide a residency program that is recognized nationally for the quality and excellence of its graduates.
The PGY2 Critical Care Residency at OSUWMC provides the resident with a well-rounded experience in a wide variety of critical care populations. This is done through required core rotations to strengthen critical care fundamentals, as well as elective rotations with the flexibility to meet the individual’s needs.Read More
The required rotations include 2 months of Surgical Intensive Care, 1 month of Medical Intensive care, 1 month of Medical Hematology/Oncology Critical Care, 2 months of Neurosciences Critical Care, and 1 month of Cardiothoracic Surgery. Potential electives include (but are not limited) to the areas of infectious diseases, solid organ transplantation, emergency medicine, trauma and burn.
The program is designed to develop the resident’s clinical expertise in critical care and provide the necessary skills in teaching, quality improvement, and management of medical emergencies. In addition, this residency has a significant focus on clinical outcomes research. To improve their research abilities, the resident will interact with clinicians with extensive research experience and participate in the Pharmacy Research Series. The PGY2 Critical Care Resident will be expected to design, implement and submit for publication at least one major outcomes based research project. Additional opportunities for research and publication are available.
Other key experiences during the residency will include completion of a longitudinal quality project, participation in a critical care patient safety committed, responsibilities for medication safety for critical care areas, preparation and delivery of at least one formal didactic lecture at The Ohio State University College of Pharmacy, and precepting of P2 IPPE students from The Ohio State University College of Pharmacy. The ultimate goal of the program is to develop independent pharmacy practitioners who will become integral members of the critical care team.
The resident will also have the opportunity to attend the ASHP Midyear Clinical Meeting, the Society of Critical Care Medicine Annual Congress, in addition to other local or regional educational seminars/conferences. Residents will be expected to present their finalized research project at the Great Lakes Pharmacy Residency Conference.
Pam Burcham, PharmD, BCPS
Kari Cape, PharmD, BCPS
Medical Intensive Care
Bruce Doepker, PharmD, BCPS
Medical Intensive Care
Tony Gerlach, PharmD, BCPS, FCCM, FCCP
Surgical Critical Care
Associate Professor, College of Pharmacy
Jessica Elefritz, PharmD, BCCCP
Hematology/Oncology Medical Intensive Care
Lisa Mostafavifar, PharmD, BCPS
Nutrition Support and Trauma/Acute Care Surgery
Claire Murphy, PharmD, BCPS, FCCM
Burn/Surgical Critical Care
Erin Reichert, PharmD, BCPS
Alan Rozycki, PharmD, BCCCP
Lindsay Ryder, PharmD, BCPS
Medical Intensive Care
Jennifer Severing, PharmD, BCPS
Mixed Medical/Surgical Critical Care, OSU East
Keaton Smetana, PharmD, BCCCP
Neurosciences Critical Care
Molly Thompson, PharmD, BCCCP
Surgical Critical Care
Selected Resident Research
- High-dose dexmedetomidine for sedation in the intensive care unit: an evaluation of clinical efficacy and safety. Ann Pharmacother 2011;45:740-7. – Jones GM, Murphy CV, Gerlach AT, Goodman EM, Pell LJ.
- Nephrotoxicity Associated with Intravenous Colistin in Critically Ill Patients. Pharmacotherapy. 2011;31:1257-64.– Doshi NM, Mount KL, and Murphy CV.
- Impact of early methadone initiation in critically ill burn patients: a pilot study. J Burn Care Res. 2013;34;342-348. – Jones GM, Porter K, Coffey R, Miller SF, Cook CH, Whitmill ML, Murphy CV.
- Adjunctive aerosolized colistin for multi-drug resistant gram-negative pneumonia in the critically ill: a retrospective study. BMC Anesthesiology. 2013;13:45. – Doshi NM, Cook CH, Mount KL, Stawicki SP, Frazee EN, Personett HA, Schramm GE, Arnold HM, Murphy CV.
- Impact of Late Fluid Balance on Clinical Outcomes in the Critically Ill Surgical and Trauma Population. J Crit Care. 2015;30:1338-43. – Elofson KA, Eiferman DA, Porter K, Murphy CV.
- Medication induced and spontaneous hypoglycemia carry the same risk of hospital mortality in critically ill patients. J Critical Care. 2016; 36:13-17.- Saliba L, Cook CH, Dungan KM, Porter K, Murphy CV.
- Colistin combination therapy improves microbiologic cure in critically ill patients with multi-drug resistant gram-negative pneumonia. Eur J Clin Microbiol Infect Dis. 2016;35:1433-9.- Parchem NL, Bauer KA, Cook CH, Mangino JE, Jones CD, Porter K, Murphy CV
- Efficacy and safety of a colistin loading dose, high-dose maintenance regimen in critically ill patients with multidrug resistant gram-negative pneumonia. J Int Care Med. 2016; [Epub ahead of print]– Elefritz J, Bauer K, Jones C, Mangino JE, Porter, K, Murphy CV.
Benefits and Additional Requirements
Application Deadline: January 2, 2018
Start Date: July 2, 2018
Annual Salary – $47,500
Vacation Days – 10 days
Staffing Requirement – 20 weekends per year
Completion of a Major Research Project